Beta-Cell Dysfunction: A Driver of T2D?

What do you know about the role of beta-cell dysfunction in the pathophysiology of type 2 diabetes (T2D)? Join primary care experts in T2D: Dr. John Anderson, Dr. Stephen Brunton, and Dr. James LaSalle as we discuss the beta-cell function and its critical role in T2D pathogenesis, what clinicians know or should know about it and how it is measured in the clinic, and how our current knowledge of beta-cell function in T2D may affect future research on T2D treatment.

This podcast is sponsored by Novo Nordisk and is intended for clinicians. The opinions expressed are those of the speakers and not Novo Nordisk.

John E. Anderson
John E. Anderson, MD, is an internal medicine and diabetes specialist at The Frist Clinic in Nashville, Tennessee.

Stephen Brunton
Stephen Brunton, MD, FAAFP, is the executive director of the Primary Care Metabolic Group in Winnsboro, South Carolina.

James LaSalle
James LaSalle, DO, FAAFP, practices at Medical Arts of Excelsior Springs, Inc. in Excelsior Springs, Missouri.


Submit Feedback